Skip to main content

Pharma News

 

Clinical courses

Get the latest news from world and India’s leading pharmaceutical companies Pharma Industry, pharmaceutical marketing, generic drugs, and Complete news for Pharmacy and Life Sciences professionals.

  • Medtronic plc announced U.S. Food and Drug Administration (FDA) approval of Medtronic Deep Brain Stimulation (DBS) Therapy for use in people with Parkinson's disease of at least four years duration and with recent onset of motor complications, or motor complications of longer-standing duration that are not adequately controlled with medication. In 2002, the FDA initially approved Medtronic DBS Therapy for use in patients with advanced Parkinson's disease. Medtronic DBS has demonstrated improvement in motor complications, quality of life, activities of daily living and reduction in medication usage in individuals with Parkinson's disease.

  • A new treatment for Middle East Respiratory Syndrome (MERS) has been found to protect mice from infection, according to a study.MERS, a disease that can cause severe respiratory symptoms and has a death rate of 40 percent, has killed nearly 600 people since it was first discovered four years ago in Saudi Arabia.

  • Offering a target for developing new therapies to address sleep disorders, researchers have identified a gene that when overactivated causes severe insomnia.

  • Tobacco products were cheaper than essential food items in India, says a new study."The current excise and Value Added Tax (VAT) rates are insufficient to increase the prices of tobacco products, therefore making these products easily affordable," said the study conducted by the Institute for Studies in Industrial Development (ISID) and Public Health Foundation of India (PHFI).

Subscribe to Pharma News